Glenmede Trust CO Na Acadia Pharmaceuticals Inc Transaction History

Glenmede Trust CO Na

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$25.02 - $54.99 $99,629 - $218,970	-3,982 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $246 - $340	-6 Reduced 0.15%	3,982 $212,000
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $1,456 - $2,280	-40 Reduced 0.99%	3,988 $164,000
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $225,862 - $303,355	-5,753 Reduced 58.82%	4,028 $195,000
Q4 2019 Feb 12, 2020	BUY	$36.21 - $51.4 $82,051 - $116,472	2,266 Added 30.15%	9,781 $418,000
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $107,433 - $212,788	4,835 Added 180.41%	7,515 $270,000
Q2 2019 Aug 13, 2019	SELL	$23.32 - $28.12 $28,800 - $34,728	-1,235 Reduced 31.55%	2,680 $71,000
Q1 2019 May 14, 2019	SELL	$16.17 - $27.38 $26,114 - $44,218	-1,615 Reduced 29.2%	3,915 $105,000
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $21,122 - $33,807	1,475 Added 36.37%	5,530 $89,000
Q3 2018 Nov 15, 2018	BUY	$13.03 - $21.81 $52,836 - $88,439	4,055 New	4,055 $84,000
Q2 2018 Aug 15, 2018	SELL	$15.07 - $22.34 $3,119 - $4,624	-207 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $6,104 - $7,942	207	207 $0

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.